Legal Opinion
1199seiu Nat'l Benefit Fund v. Allergan, Inc. (In re Restasis (Cyclosporine Ophthalmic Emulsion) Antitrust Litig.)
District Court, E.D. New York
Decided September 17, 2018No. 18-MD-2819 (NG) (LB)PublishedCited by 4 opinions
1Opinion of the Court
GERSHON, United States District Judge:
TABLE OF CONTENTS
I. INTRODUCTION...140
II. PLAINTIFFS' ALLEGATIONS...141
A. Allergan's Development of Restasis®...141
B. Allergan's Unsuccessful Attempts to Obtain a Second-Wave Patent on Restasis®...142
C. Applications for FDA approval of Generic Versions of Restasis®...143
D. Allergan's Alleged Improper Efforts to Delay Generic Versions of Restasis®...144
1. Submitting Sham Citizen Petitions to the FDA...144
2. Defrauding the USPTO into Issuing Second-Wave Patents...147
3. Wrongfully Listing the Second-Wave Patents in the Orange Book...149
4. Filing a Series of…
2Cases cited24 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- Zenith Radio Corp. v. Hazeltine Research, Inc.Supreme Court of the United States · 1969
- Eastern Railroad Presidents Conference v. Noerr Motor Freight, Inc.Supreme Court of the United States · 1961
19 more not listed; retrieve them via the Exa API.
3Cited by4 opinions
- In re Restasis (Cyclosporine Ophthalmic Emulsion) Antitrust Litig.District Court, E.D. New York · 2019
- Amicus Therapeutics US, LLC v. Teva Pharmaceuticals USA, Inc.District Court, D. Delaware · 2023
- United Food & Com. Workers Local 1776 Meijer, Inc. v. Takeda Pharm. Co.Court of Appeals for the Second Circuit · 2021
- VALUE DRUG COMPANY v. TAKEDA PHARMACEUTICALS, U.S.A., INC.District Court, E.D. Pennsylvania · 2022